Department of Ophthalmology, Guangzhou Women and Children's Medical Center, No. 9, Jinsui Road, Tianhe District, Guangzhou City, 510623, China.
Department of Ophthalmology, Nanfang Hospital, Southern Medical University, Guangzhou City, 510515, China.
Graefes Arch Clin Exp Ophthalmol. 2023 Mar;261(3):723-734. doi: 10.1007/s00417-022-05956-4. Epub 2022 Dec 28.
This study was aimed at exploring the function of Exosomes isolated from bone marrow-derived mesenchymal stem cells (BMSC-Exos) in corneal wound healing and at revealing the underlying mechanisms involving the p44/42 mitogen-activated protein kinase (MAPK) pathway.
The isolated BMSC-Exos were identified by transmission electron microscopy, Western blot, and nanoparticle tracking analysis. After coculture with BMSC-Exos, the proliferation and migration of human corneal epithelial cells (HCEs) were evaluated. The protein expression of p-MEK/MEK and p44/42 MAPK was detected by Western blot. A mouse model of alkali-burned cornea was established via NaOH exposure. After injection with BMSC-Exos, the pathological changes and expression of α-SMA (a fibrosis marker) and CD31 (a vascularization marker) in corneal tissues were detected.
BMSC-Exos enhanced the proliferation and migration of HCEs in a dose-dependent manner. The p44/42 MAPK pathway was activated by the treatment of BMSC-Exos, and its blocking using U0126 partially abrogated the effects of BMSC-Exos on promoting the proliferation and migration of HCEs. In vivo, the injection of BMSC-Exos facilitated the remission of the pathological changes (inflammation) and weakened the upregulation of α-SMA (fibrosis) and CD31 (vascularization) in corneal tissues of mice with alkali-burn injury.
BMSC-Exos promoted the proliferation and migration of HCEs via activating the p44/42 MAPK pathway in vitro and also inhibited alkali burn-induced inflammation, fibrosis, and vascularization in corneal tissues in vivo. BMSC-Exos may be promising resources for promoting corneal wound healing.
本研究旨在探讨骨髓间充质干细胞来源的外泌体(BMSC-Exos)在角膜伤口愈合中的作用,并揭示涉及丝裂原活化蛋白激酶(MAPK)通路的 p44/42 的潜在机制。
通过透射电子显微镜、Western blot 和纳米颗粒跟踪分析鉴定分离的 BMSC-Exos。BMSC-Exos 共培养后,评估人角膜上皮细胞(HCE)的增殖和迁移。Western blot 检测 p-MEK/MEK 和 p44/42 MAPK 的蛋白表达。通过 NaOH 暴露建立碱烧伤角膜小鼠模型。注射 BMSC-Exos 后,检测角膜组织中α-SMA(纤维化标志物)和 CD31(血管生成标志物)的病理变化和表达。
BMSC-Exos 以剂量依赖的方式增强 HCE 的增殖和迁移。BMSC-Exos 处理激活了 p44/42 MAPK 通路,用 U0126 阻断其通路可部分阻断 BMSC-Exos 促进 HCE 增殖和迁移的作用。体内,BMSC-Exos 促进了碱烧伤损伤小鼠角膜组织中病理变化(炎症)的缓解,并减弱了α-SMA(纤维化)和 CD31(血管生成)的上调。
BMSC-Exos 通过体外激活 p44/42 MAPK 通路促进 HCE 的增殖和迁移,还抑制了体内碱烧伤诱导的角膜组织炎症、纤维化和血管生成。BMSC-Exos 可能是促进角膜伤口愈合的有前途的资源。